Abbott ABT Medical Devices — Remaining performance obligations

Other segment segments

Similar metrics at other companies

FTVAdvanced Healthcare Solutions — Total remaining performance obligations

$112.9M+10.8%

BIIBContract manufacturing and other revenue — Remaining performance obligation, remaining amount

$153.8M—

MRNANet product sales — Remaining performance obligations

$79M-78.1%

FICODecision Management Software — Revenue Remaining Performance Obligation

$30.45M—

FTVOperating Segments — Revenue Remaining Performance Obligation

$658M—

AWK

AWKMarket-Based Businesses and Other — Revenue, remaining performance obligation

$7B—

Questions, answered.

What is Abbott's medical devices — remaining performance obligations?

Abbott (ABT) reported medical devices — remaining performance obligations of $429M in Q1 2026.

How has Abbott's medical devices — remaining performance obligations changed year-over-year?

Abbott's medical devices — remaining performance obligations increased by 1.4% year-over-year, from $423M to $429M.

What is the long-term trend for Abbott's medical devices — remaining performance obligations?

Over 4 years (2021 to 2025), Abbott's medical devices — remaining performance obligations has grown at a 0.5% compound annual growth rate (CAGR), from $1.69B to $1.73B.

What does medical devices — remaining performance obligations mean?

The total value of contracted work that has not yet been delivered or recognized as revenue.

How do you interpret medical devices — remaining performance obligations?

An increase suggests a growing backlog of future business, while a decrease may indicate a slowdown in new contract signings or faster fulfillment.

How does medical devices — remaining performance obligations compare across companies?

Common in companies with service-heavy or long-term contract-based medical device business models.